Platelets 2013
DOI: 10.1016/b978-0-12-387837-3.00052-3
|View full text |Cite
|
Sign up to set email alerts
|

Cardiopulmonary Bypass

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2016
2016
2019
2019

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 265 publications
0
5
0
Order By: Relevance
“…The discussion of platelet passivation of biomaterials in the context of cardiopulmonary bypass can also be found in Ref. 47. Similarly, Kang et al observed a-granule secretion in platelets adhering on peptide-coated glass surfaces only at a specific range of water contact angles (surface hydrophobicities); on the contrary, dense granule secretion did not depend on the surface properties but only on the number of the adhering platelets.…”
Section: Discussionmentioning
confidence: 95%
“…The discussion of platelet passivation of biomaterials in the context of cardiopulmonary bypass can also be found in Ref. 47. Similarly, Kang et al observed a-granule secretion in platelets adhering on peptide-coated glass surfaces only at a specific range of water contact angles (surface hydrophobicities); on the contrary, dense granule secretion did not depend on the surface properties but only on the number of the adhering platelets.…”
Section: Discussionmentioning
confidence: 95%
“…13,14 It adds to the growing body of evidence that artificial surfaces exhibit properties that are similar to those of classical platelet agonists, and that responses of platelets to different surfaces are different. 20,21,[23][24][25][26] Most likely, the surface-platelet signaling is mediated by the adsorbed proteins. 27,28 Properly studied, these phenomena offer a possibility to improve the control over the response of platelets to artificial surfaces.…”
Section: Resultsmentioning
confidence: 99%
“…In this study, we found that platelet dysfunction, as measured by response to collagen near the end of bypass, was independently associated with adverse postoperative outcomes. The milieu of haemostatic activation; elevated thrombin and plasmin levels; complement activation; contact with foreign materials (bypass circuit, cannulas); and interaction with circuit‐adhered immune cells, such as neutrophils, leading to platelet activation , could all lead to dysregulation of platelet surface proteins (gycoproteins, p‐selectin, CD31) and abnormal aggregation .…”
Section: Discussionmentioning
confidence: 99%
“…The safe use of cardiopulmonary bypass during surgery requires profound anticoagulation to prevent haemostatic activation resulting from contact between blood and the bypass circuit . Despite anticoagulation, the conduct of bypass results in varying levels of haemostatic activation characterised by upregulation of thrombin, consumption of coagulation factors and platelet dysfunction . This haemostatic activation can lead to peri‐operative coagulopathy or, paradoxically, postoperative thromboembolic complications such as acute kidney injury, stroke, myocardial infarction, deep vein thrombosis and pulmonary embolism .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation